Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| African Americans | 14 | 2014 | 256 | 2.380 |
Why?
|
| Aged | 21 | 2014 | 1188 | 1.010 |
Why?
|
| Aged, 80 and over | 16 | 2014 | 407 | 0.850 |
Why?
|
| Male | 21 | 2014 | 2620 | 0.770 |
Why?
|
| Humans | 28 | 2014 | 4931 | 0.720 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2003 | 8 | 0.690 |
Why?
|
| Female | 20 | 2014 | 2964 | 0.680 |
Why?
|
| Adult | 14 | 2014 | 1402 | 0.670 |
Why?
|
| Retrospective Studies | 12 | 2014 | 513 | 0.670 |
Why?
|
| Middle Aged | 14 | 2014 | 1544 | 0.570 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2005 | 22 | 0.560 |
Why?
|
| Pancreatitis | 2 | 2007 | 6 | 0.520 |
Why?
|
| Hepatitis C | 2 | 2006 | 15 | 0.500 |
Why?
|
| Diarrhea | 2 | 2007 | 8 | 0.480 |
Why?
|
| Colonoscopy | 3 | 2011 | 8 | 0.470 |
Why?
|
| Choledocholithiasis | 1 | 2014 | 1 | 0.450 |
Why?
|
| Pain Measurement | 1 | 2014 | 45 | 0.440 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 8 | 0.410 |
Why?
|
| Hepatic Encephalopathy | 2 | 2002 | 2 | 0.390 |
Why?
|
| United States | 8 | 2011 | 764 | 0.370 |
Why?
|
| Mallory-Weiss Syndrome | 1 | 2011 | 1 | 0.360 |
Why?
|
| Conscious Sedation | 1 | 2011 | 3 | 0.360 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 17 | 0.350 |
Why?
|
| Treatment Outcome | 2 | 2014 | 402 | 0.350 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2007 | 16 | 0.330 |
Why?
|
| Frail Elderly | 3 | 2005 | 9 | 0.320 |
Why?
|
| Risk Factors | 5 | 2011 | 593 | 0.290 |
Why?
|
| Jaundice | 1 | 2007 | 3 | 0.290 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 5 | 0.290 |
Why?
|
| Prevalence | 5 | 2007 | 184 | 0.280 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 2 | 0.280 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 2 | 0.280 |
Why?
|
| Cross Infection | 1 | 2007 | 10 | 0.270 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 2 | 0.260 |
Why?
|
| Colonic Diseases | 1 | 2006 | 3 | 0.260 |
Why?
|
| Nursing Homes | 2 | 2005 | 7 | 0.260 |
Why?
|
| Colon | 1 | 2006 | 16 | 0.260 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 29 | 0.250 |
Why?
|
| Los Angeles | 5 | 2011 | 244 | 0.250 |
Why?
|
| Comorbidity | 4 | 2011 | 123 | 0.240 |
Why?
|
| Age Factors | 3 | 2014 | 152 | 0.240 |
Why?
|
| Arthritis, Infectious | 1 | 2005 | 2 | 0.240 |
Why?
|
| Interferon-alpha | 1 | 2005 | 2 | 0.240 |
Why?
|
| Antiviral Agents | 1 | 2005 | 10 | 0.240 |
Why?
|
| HIV Infections | 2 | 2007 | 167 | 0.240 |
Why?
|
| Fecal Incontinence | 1 | 2005 | 4 | 0.230 |
Why?
|
| Dyspepsia | 1 | 2004 | 2 | 0.220 |
Why?
|
| Liver Diseases | 2 | 2011 | 15 | 0.220 |
Why?
|
| Succimer | 1 | 2003 | 1 | 0.220 |
Why?
|
| Lead Poisoning | 1 | 2003 | 3 | 0.210 |
Why?
|
| Esophageal Diseases | 1 | 2003 | 1 | 0.210 |
Why?
|
| Wounds, Gunshot | 1 | 2003 | 15 | 0.210 |
Why?
|
| Chelating Agents | 1 | 2003 | 11 | 0.210 |
Why?
|
| Colonic Polyps | 1 | 2003 | 1 | 0.210 |
Why?
|
| Skin Diseases | 1 | 2003 | 2 | 0.210 |
Why?
|
| Esophagus | 1 | 2003 | 12 | 0.210 |
Why?
|
| Administration, Oral | 1 | 2003 | 36 | 0.210 |
Why?
|
| Syphilis | 1 | 2003 | 4 | 0.210 |
Why?
|
| Myocardial Infarction | 2 | 2002 | 41 | 0.210 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 5 | 0.200 |
Why?
|
| Minority Groups | 1 | 2003 | 53 | 0.200 |
Why?
|
| Urban Population | 3 | 2014 | 64 | 0.200 |
Why?
|
| Conjunctival Diseases | 1 | 2002 | 1 | 0.190 |
Why?
|
| Liver Failure | 1 | 2002 | 3 | 0.190 |
Why?
|
| Edema | 1 | 2002 | 5 | 0.190 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2011 | 6 | 0.190 |
Why?
|
| Young Adult | 2 | 2014 | 382 | 0.180 |
Why?
|
| Physical Examination | 1 | 2000 | 6 | 0.170 |
Why?
|
| Rectum | 1 | 2000 | 7 | 0.170 |
Why?
|
| Abdominal Pain | 2 | 2014 | 7 | 0.170 |
Why?
|
| Odds Ratio | 2 | 2014 | 67 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2014 | 162 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2014 | 224 | 0.150 |
Why?
|
| California | 2 | 2014 | 161 | 0.150 |
Why?
|
| Hospitals, Urban | 2 | 2011 | 7 | 0.140 |
Why?
|
| Adolescent | 2 | 2011 | 569 | 0.140 |
Why?
|
| Acute Disease | 2 | 2007 | 23 | 0.130 |
Why?
|
| Biomarkers | 2 | 2007 | 160 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2007 | 70 | 0.110 |
Why?
|
| Biliary Tract | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cholecystectomy | 1 | 2014 | 3 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 3 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2014 | 15 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 76 | 0.110 |
Why?
|
| Algorithms | 2 | 2005 | 69 | 0.110 |
Why?
|
| Sex Factors | 1 | 2014 | 120 | 0.110 |
Why?
|
| Age Distribution | 2 | 2003 | 33 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 202 | 0.110 |
Why?
|
| Prognosis | 2 | 2003 | 167 | 0.100 |
Why?
|
| Recurrence | 1 | 2011 | 25 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 35 | 0.090 |
Why?
|
| Cholestasis | 1 | 2011 | 7 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 7 | 0.090 |
Why?
|
| Liver Function Tests | 1 | 2007 | 4 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 6 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 45 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 9 | 0.070 |
Why?
|
| Hospitalization | 1 | 2007 | 106 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 127 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2005 | 6 | 0.060 |
Why?
|
| Arthralgia | 1 | 2005 | 2 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 36 | 0.060 |
Why?
|
| Inflammation | 1 | 2006 | 122 | 0.060 |
Why?
|
| Pregnancy | 1 | 2006 | 417 | 0.060 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2004 | 2 | 0.060 |
Why?
|
| Gallstones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 6 | 0.060 |
Why?
|
| Radiography | 1 | 2004 | 16 | 0.060 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 1 | 0.050 |
Why?
|
| Sigmoidoscopy | 1 | 2003 | 2 | 0.050 |
Why?
|
| Decision Trees | 1 | 2003 | 5 | 0.050 |
Why?
|
| Resuscitation | 1 | 2003 | 5 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 2003 | 1 | 0.050 |
Why?
|
| Lead | 1 | 2003 | 2 | 0.050 |
Why?
|
| Antacids | 1 | 2003 | 1 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2003 | 1 | 0.050 |
Why?
|
| Protons | 1 | 2003 | 1 | 0.050 |
Why?
|
| Sucralfate | 1 | 2003 | 1 | 0.050 |
Why?
|
| Endoscopy | 1 | 2003 | 6 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2003 | 4 | 0.050 |
Why?
|
| Patient Selection | 1 | 2003 | 31 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2003 | 35 | 0.050 |
Why?
|
| Coinfection | 1 | 2003 | 3 | 0.050 |
Why?
|
| Preventive Health Services | 1 | 2003 | 16 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2003 | 24 | 0.050 |
Why?
|
| Infection Control | 1 | 2003 | 7 | 0.050 |
Why?
|
| Life Style | 1 | 2003 | 44 | 0.050 |
Why?
|
| Incidence | 1 | 2003 | 141 | 0.050 |
Why?
|
| Time Factors | 1 | 2003 | 245 | 0.050 |
Why?
|
| Cellulitis | 1 | 2002 | 1 | 0.050 |
Why?
|
| Meningitis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Pneumonia | 1 | 2002 | 3 | 0.050 |
Why?
|
| Sepsis | 1 | 2002 | 5 | 0.050 |
Why?
|
| Peritonitis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2002 | 4 | 0.050 |
Why?
|
| Medical Records | 1 | 2002 | 21 | 0.050 |
Why?
|
| Craniocerebral Trauma | 1 | 2002 | 9 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 45 | 0.050 |
Why?
|
| Medical Audit | 1 | 2002 | 11 | 0.050 |
Why?
|
| Stroke | 1 | 2002 | 41 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 39 | 0.050 |
Why?
|
| Safety | 1 | 2000 | 15 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 14 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2000 | 29 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2000 | 229 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 13 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2011 | 14 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 17 | 0.020 |
Why?
|
| Social Class | 1 | 2003 | 34 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 358 | 0.010 |
Why?
|